We have recently demonstrated that the LPS-plus-MV induced-mouse model of ARDS triggers extracellular ATP and subsequent NLRP3 activation followed by IL-1β release in the lungs that led to lung inflammation, severe hypoxemia as well as increased lung permeability (12). The gene discussed is NLRP3; the disease is acute respiratory distress syndrome.